Epigenetic control of 11 beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension

Atherosclerosis

Volumn 199, Issue 2, 2008, Pages 323-327

  Friso, Simonetta ^a   Pizzolo, Francesca ^a   Choi, Sang Woon ^b   Guarini, Patrizia ^a   Castagna, Annalisa ^a   Ravagnani, Viviana ^a   Carletto, Antonio ^a   Pattini, Patrizia ^a   Corrocher, Roberto ^a   Olivieri, Oliviero ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b TUFTS UNIVERSITY   (United States)

Author keywords

11Beta HSD2; Cortisol to cortisone metabolites ratio; DNA methylation; Epigenetics; Gene expression; HSD11B2; Hypertension; Peripheral blood mononuclear cells; THFs THE ratio

Indexed keywords

DNA; PREDNISONE; TETRAHYDROCORTISONE;

11 BETA HYDROXYSTEROID DEHYDROGENASE 2 GENE; ADULT; ARTICLE; BLOOD PRESSURE REGULATION; ESSENTIAL HYPERTENSION; FEMALE; GENE; GENE FUNCTION; GENETIC REGULATION; HUMAN; HUMAN CELL; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METHYLATION; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; AGED; DNA; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPERTENSION; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PREDNISONE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC;

EID: 47649085663     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.11.029     Document Type: Article

References (20)

1. Ferrari P., and Krozowsky Z. Role of the 11beta-hydroxysteroid dehydrogenase type 2 in blood pressure regulation. Kidney Int 57 (2000) 1374-1381
2. Mariniello B., Ronconi V., Sardu C., et al. Analysis of the 11b-hydroxysteroid dehydrogenase type 2 gene (HSD11B2) in human essential hypertension. Am J Hypertens 18 (2005) 1091-1098
3. Carvajal C.A., Romero D.G., Mosso L.M., et al. Biochemical and genetic characterization of 11β-hydroxysteroid dehydrogenase type 2 in low-renin essential hypertensives. J Hypertens 23 (2005) 71-77
4. Ferrari P., Sansonnens A., Dick B., and Frey F.J. In vivo 11beta-HSD2 activity: variability, sensitivity and effect of licorice. Hypertension 38 (2001) 1330-1336
5. Frey F.J., Odermatt A., and Frey B.M. Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension. Curr Opin Nephrol Hypertens 13 (2004) 451-458
6. Naray-Fejes-Toth A., Watlington C.O., and Fejes-Toth G. 11 Beta-hydroxysteroid dehydrogenase activity in the renal target cells of aldosterone. Endocrinology 129 (1991) 17-21
7. Stewart P.M., Corrie J.E., Shackleton C.H., and Edwards C.R. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. J Clin Invest 82 (1988) 340-349
8. Kotelevtsev Y., Brown R.W., Fleming S., et al. Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2. J Clin Invest 103 (1999) 683-689
9. Quinkler M., Zehnder D., Lepenies J., et al. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function. Eur J Endocrinol 153 (2005) 291-299
10. Williams A.T., Mulatero P., Filigheddu F., et al. Role of HSD11B2 polymorphism in essential hypertension and the diuretic response to thiazides. Kidney Int 67 (2005) 631-637
11. Alikhani-Koopaei R., Fouladkou F., Frey F.J., and Frey B.M. Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression. J Clin Invest 114 (2004) 1146-1157
12. Olivieri O., Ciacciarelli A., Signorelli D., et al. Aldosterone to renin ratio in a primary care setting: the Bussolengo study. J Clin Endocrinol Metab 89 (2004) 4221-4226
13. Shackleton C.H. Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research. J Steroid Biochem Mol Biol 45 (1993) 127-140
14. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93 18 (1996) 9821-9826
15. Robertson K.D., and Wolffe A.P. DNA methylation in health and disease. Nat Rev Genet 1 (2000) 11-19
16. Friso S., and Choi S.W. Gene-nutrient interactions and DNA methylation. J Nutr 132 (2002) 2382S-2387S
17. Kim M.H., Kim E., Passen E.L., Meyer J., and Kang S.S. Cortisol and estradiol: nongenetic factors for hyperhomocyst(e)inemia. Metabolism 46 (1997) 247-249
18. Rowling J.M., and Schalinske K.L. Retinoic acid and glucocorticoid treatment induce hepatic glycine N-methyltransferase and lower plasma homocysteine concentrations in rats and rat hepatoma cells. J Nutr 133 (2003) 3392-3398
19. Enokido Y., Suzuki E., Iwasawa K., et al. Cystathionine beta-synthase, a key enzyme for homocysteine metabolism, is preferentially expressed in the radial glia/astrocyte lineage of developing mouse CNS. FASEB J 19 (2005) 1854-1856
20. Friso S., Choi S.W., Girelli D., et al. A common mutation in the 5, 10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 99 (2002) 5606-5611